Table 2.
Source | Purpose | Patches, n | TIL-positive, n | TIL-negative, n |
---|---|---|---|---|
TCGA | Training | 86,154 | 21,773 | 64,381 |
Validation | 653 | 295 | 357 | |
Testing | 327 | 174 | 153 |
Data set provided in Saltz et al.31
TIL, tumor-infiltrating lymphocyte; TCGA, The Cancer Genome Atlas.